RxDoctor Payments Data

Alicia Rios

Family · Palm Springs, CANPI 1033885991

Payments from drug & device makers

$3,847in general payments, 2019–2025

Across 145 payments — averaging $26.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Novo Nordisk$507
  • AbbVie$239
  • Philips North America LLC$210
  • GSK$190
  • Bayer$183
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,847100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,847 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide153$154,865
TrulicityDulaglutide57$61,301
MounjaroTirzepatide36$40,170
XifaxanRifaximin11$38,954
RybelsusSemaglutide18$32,784
LinzessLinaclotide40$32,491
JardianceEmpagliflozin19$23,682
Repatha SureclickEvolocumab25$22,054
MyrbetriqMirabegron16$17,991
FarxigaDapagliflozin Propanediol11$12,994
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,994
Clonidine18$2,794
Atorvastatin Calcium167$2,703
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,292
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$1,596

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$507$187,649171 claims
Lilly USA, LLCTrulicity, Mounjaro$146$101,47193 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$83$38,95411 claims
AbbVieLinzess$239$32,49140 claims
AstraZenecaFarxiga$162$12,99411 claims
GSKTrelegy Ellipta$190$9,99415 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$24$30221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Palm Springs

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →